IRCT2013111915444N2已完成2 期
Effect of deferoxamine on hemorrhagic transformation of middle cerebral artery stroke
Vice chancellor for research, Ahvaz Jondishapur University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Acute ischemic stroke in middle cerebral artery territory. Exclusion criteria: renal failure; hemorrhagic stroke; stroke in other arterial territory; coagulopathies and history of anticoagulant drugs; anemia
排除标准
- 未提供
研究者
相似试验
招募中
3 期
implication of Deferoxamine in the treatment of kienbock’s diseaseKienböck disease of adults.Adult osteochondrosis of carpal lunateIRCT2017073035382N1Vice Chancellor for research of Iran University of Medical Sciences10
进行中（未招募）
1 期
The use of a chelator in patients with aneurysmal cerebral hemorrhagepatients with aneurysmal subarachnoid hemorrhageMedDRA version: 16.1Level: HLTClassification code 10007936Term: Central nervous system aneurysmsSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10022758Term: Intracranial aneurysmSystem Organ Class: 10029205 - Nervous system disordersEUCTR2016-002784-34-NLRadboudumc20
撤回
不适用
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trialNL-OMON45310Radboud Universitair Medisch Centrum40
招募中
2 期
Deferoxamine in Aneurysmal Subarachnoid Hemorrhage trialDelayed cerebral ischemia100079631000318410002363cerebral vasospasmNL-OMON52890Radboud Universitair Medisch Centrum40
已完成
3 期
deferoxamine and its cardiotoxicity effectsacute and chronic cardiopathy.Heart disease, unspecifiedIRCT2016080615666N5Vice chancellor of research, Shiaz Univeisity of Medical Sciences60